WPQW granule

Developed for: gastroesophageal reflux disease · irritable bowel syndrome
Investigated by: Affiliated Hospital of Liaoning University of Traditional Chinese Medicine · The First Affiliated Hospital of Henan University of Traditional Chinese Medicine · The First Affiliated Hospital of Shanxi University of Traditional Chinese Medicine · Tianjin Nankai Hospital · Xiyuan Hospital of China Academy of Chinese Medical Sciences · Yunnan Provinical Hospital of Traditional Chinese Medicine

today NCT05369884 · Ph 0

20222023202420252026

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 0	NCT05369884	Dec 2021 → May 2023	gastroesophageal reflux disease, irritable bowel syndrome	Xiyuan Hospital of China Academy of Chinese Medical Sciences	Unknown	No outcome recorded

Every value below carries the sentence it was read from. 1 source stands behind the page.

Field	Value	Cited text
Known as	WPQW granule	ClinicalTrials.gov intervention name — accepted as the source's own label NCT05369884 ↗
Route	Oral	“Oral administration of WPQW granule with warm water” NCT05369884 ↗